493-P: Do Spanish Language Pictograms Reflect Objective Physical Activity Data in Hispanics/Latinos with or at Risk of Type 2 Diabetes?

Abstract

Assessing physical activity (PA) in Hispanics/Latinos with/at risk of type 2 diabetes (T2D) may be challenging due to language, health literacy, and cultural barriers. We compared self-reported PA using Spanish-language pictograms (SP) with objectively assessed PA data in Hispanic/Latino adults with low education, with or at risk of T2D.Subjects [n=102, 67 women, 88 T2D, age 58.2±10.3 years, BMI 31.3±5.7, HbA1c% 7.9±2.0, (mean±SD), and approximately 50% have less than high school education] wore an Actigraph (AG) on the dominant hip to objectively monitor PA (steps) for 7 days stratified by time (6am-12pm, 12pm-6pm, 6pm-12am) and subjectively assessed PA, using SP, (stratified as sleep, sedentary rest and work, housework, manual work, and exercise) and 10-point Likert scale (1 “not active” to 10 “very, very active”). Subjects worked 5 (0-7) [median (range)] days with 3 also working (sedentary) at weekends. Most participants were asleep 12am - 6am, and 3 worked nights.Subjects self-perceived as very active (7.4±2.1 Likert score) at work. Barring exercise, objectively measured PA increased with SP-reported PA.Spanish language pictograms to measure PA may have value in physical activity monitoring in Hispanics/Latinos with low education and with or at risk of T2D.View largeDownload slideView largeDownload slide DisclosureD. Haj: None. W. C. Bevier: Research Support; Self; Abbott Diabetes, Eli Lilly and Company. A. J. Larez: Research Support; Self; Abbott, Eli Lilly and Company. C. Conneely: Research Support; Self; Abbott, Eli Lilly and Company. N. M. Glantz: Research Support; Self; Abbott, Eli Lilly and Company. K. N. Castorino: Consultant; Self; Dexcom, Inc., Research Support; Self; Abbott Diabetes, Abbott Laboratories, Dexcom, Inc., Drawbridge Health, Inc., Lilly Diabetes, Medtronic, Novo Nordisk Inc. D. Kerr: Advisory Panel; Self; Novo Nordisk, Sanofi-Aventis, Research Support; Self; Abbott Diabetes, Elsevier, Lilly Diabetes, Stock/Shareholder; Self; Glooko, Inc.FundingEli Lilly and Company